United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2014_register
executive
2014-01-11
article
Advisory Committee; Pharmacy Compounding Advisory Committee
Rules and Regulations
D09002ee1bdc83a9c
D09002ee1bdc84121
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is amending its regulations to update information regarding the Pharmacy Compounding Advisory Committee in FDA's Center for Drug Evaluation and Research in the Agency's list of standing advisory committees. This updated information regarding the Committee includes changes to its charter to reflect the recent enactment of the Drug Quality and Security Act.
79 FR 2093
https://www.govinfo.gov/app/details/FR-2014-01-13/2014-00322
2014-00322
fr13ja14-5
4160-01-P
Docket No. FDA-2013-N-1687
https://www.govinfo.gov/app/details/FR-2014-01-13/2014-00322
https://www.govinfo.gov/content/pkg/FR-2014-01-13/html/2014-00322.htm
https://www.govinfo.gov/content/pkg/FR-2014-01-13/pdf/2014-00322.pdf
Administrative Practice and Procedure
Advisory Committees
Color Additives
Drugs
Radiation Protection
2 p.
2093
2094
79 FR 2093
Code of Federal Regulations
Title 21 Part 14
21 CFR Part 14
Advisory Committee; Pharmacy Compounding Advisory Committee; Federal Register Vol. 79, Issue
RULE
2014-00322
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2014-01-13
Docket No. FDA-2013-N-1687
4160-01-P
2014-00322
Final rule.
The Food and Drug Administration (FDA) is amending its regulations to update information regarding the Pharmacy Compounding Advisory Committee in FDA's Center for Drug Evaluation and Research in the Agency's list of standing advisory committees. This updated information regarding the Committee includes changes to its charter to reflect the recent enactment of the Drug Quality and Security Act.
This rule is effective January 13, 2014.
Jayne E. Peterson, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, FAX 301-847-8533, email: PCAC@fda.hhs.gov.
Administrative Practice and Procedure
Advisory Committees
Color Additives
Drugs
Radiation Protection
Pharmacy Compounding Advisory Committee
,
PCAC@fda.hhs.gov
Federal Register
Vol. 79, no. 8
Office of the Federal Register, National Archives and Records Administration
2014-01-13
continuing
daily
deposited
born digital
294 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2014-01-13
P0b002ee186cf8a12
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr13ja14
https://www.govinfo.gov/app/details/FR-2014-01-13
https://www.govinfo.gov/content/pkg/FR-2014-01-13/pdf/FR-2014-01-13.pdf
https://www.govinfo.gov/content/pkg/FR-2014-01-13/xml/FR-2014-01-13.xml
fdlp
2075
2358
DGPO
2014-01-11
2023-04-29
FR-2014-01-13
machine generated
eng
FR
FR-2014-01-13
79
8